Annual Conference on Tularemia

兔热病年会

• 批准号: 7058907
• 负责人: DENNIS W METZGER
• 金额: $ 3万
• 依托单位: ALBANY MEDICAL COLLEGE
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-09-01 至 2010-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7058907
• 关键词: Francisella tularensis; bacterial cytopathogenic effect; bacterial vaccines; bioterrorism /chemical warfare; meeting /conference /symposium; travel; tularemia; vaccine development

Francisella tularensis is a category A biothreat agent. Since 9/11/2001, the number of laboratories studying this organism has expanded dramatically. Thus, it is important that investigators (new and experienced in the field) meet on an annual basis to share their findings and define future research goals. The proposed Tularemia Conference will provide, on an annual basis, an international forum for tularemia researchers to interact and share their knowledge. The specific goal of this meeting is to provide an opportunity for members of the tularemia community, including new investigators and trainees, to present and discuss their research, exchange ideas, and develop collaborations. This conference has occurred five times previously, four times (at 3-4 year intervals) as the "International Conference on Tularemia", the last occurring in 2003 in Bath, England. The fifth meeting, the NIAID Tularemia Workshop at the Rocky Mountain Laboratories, Hamilton, MT, was held in October of 2004 to facilitate a more timely exchange of information between new and experienced investigators. The 2003 meeting in Bath England included approximately 125 participants from around the world. The 2004 meeting in Hamilton, MT, had approximately 115 participants. The next meeting will be held November 6-8, 2005, at the Jiminy Peak Mountain Resort in Hancock, MA. It is anticipated that the 2005 meeting will include over 125 participants from the United States, as well as other countries. This will be followed by an International Conference on Tularemia in November, 2006 and an annual meeting/workshop thereafter. The focus of these meetings will be on mechanisms of F. tularensis infection and pathogenesis, as well as vaccine development. Funds requested in this application will be used primarily to allow new investigators with limited resources (e.g., R21 recipients) as well as trainees, to participate in these meetings.

土拉弗朗西斯菌是 A 类生物威胁因子。自2001年9月11日以来，研究这种生物体的实验室数量急剧增加。因此，研究人员（该领域的新的和经验丰富的）每年举行一次会议以分享他们的发现并确定未来的研究目标非常重要。拟议的土拉菌病会议将为土拉菌病研究人员每年提供一个互动和分享知识的国际论坛。这次会议的具体目标是为土拉菌病界的成员（包括新的研究人员和学员）提供一个机会，展示和讨论他们的研究成果 研究、交流想法、发展合作。该会议此前已举办过五届，其中四届为“兔热病国际会议”（每隔 3-4 年一次），最后一次于 2003 年在英国巴斯举行。第五次会议，即 2004 年 10 月在蒙大拿州汉密尔顿落基山实验室举行的 NIAID 兔热病研讨会，旨在促进新研究者和经验丰富的研究者之间更及时地交流信息。 2003 年在英格兰巴斯举行的会议约有 125 名来自世界各地的与会者。 2004 年在蒙大拿州汉密尔顿举行的会议约有 115 名与会者。下一次会议将于 2005 年 11 月 6 日至 8 日在马萨诸塞州汉考克的吉米尼峰避暑山庄举行。预计 2005 年会议将有来自美国以及其他国家的超过 125 名与会者 国家。随后将于 2006 年 11 月召开国际兔热病会议，并随后召开年度会议/研讨会。这些会议的重点将是土拉菌感染和发病机制以及疫苗开发。本申请中请求的资金将主要用于允许资源有限的新研究人员（例如 R21 接受者）以及受训人员参加这些会议。